Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Phenotypic study of humanized mice carrying the PAH deep intronic variant c.1199+502A>T

View through CrossRef
Abstract Background The c.1199 + 502 A > T variant of the phenylalanine hydroxylase (PAH) gene, which is the most frequently reported deep intronic variant involved in phenylketonuria (PKU), is mainly observed in patients with classical or mild PKU. Prior to this study, no mouse models of PKU featuring deep intronic variants of PAH had been reported. Methods To phenotypically simulate the pathogenicity of this variant, we used CRISPR/Cas9 genome editing technology and homologous recombination to generate homozygous PKU model mice with a partially humanized Pah gene incorporating human PAH exons 11–12 carrying c.1199 + 502 A > T or wild-type (c.1199 + 502WT) control sequences. Results Humanized homozygous Pah c.1199 + 502 A > T mice exhibited a classical PKU phenotype, including a higher serum phenylalanine concentration, yellowing of the fur, and other traits. The homozygous mutant group had poorer spatial learning and spatial memory compared with the wild-type group. Conclusion This construction of the first humanized mice carrying a deep intronic variant of PAH provides a new animal model for the pathogenesis and treatment of PKU, and may serve as a reference for future research on the pathogenicity of deep intronic variation.
Title: Phenotypic study of humanized mice carrying the PAH deep intronic variant c.1199+502A>T
Description:
Abstract Background The c.
1199 + 502 A > T variant of the phenylalanine hydroxylase (PAH) gene, which is the most frequently reported deep intronic variant involved in phenylketonuria (PKU), is mainly observed in patients with classical or mild PKU.
Prior to this study, no mouse models of PKU featuring deep intronic variants of PAH had been reported.
Methods To phenotypically simulate the pathogenicity of this variant, we used CRISPR/Cas9 genome editing technology and homologous recombination to generate homozygous PKU model mice with a partially humanized Pah gene incorporating human PAH exons 11–12 carrying c.
1199 + 502 A > T or wild-type (c.
1199 + 502WT) control sequences.
Results Humanized homozygous Pah c.
1199 + 502 A > T mice exhibited a classical PKU phenotype, including a higher serum phenylalanine concentration, yellowing of the fur, and other traits.
The homozygous mutant group had poorer spatial learning and spatial memory compared with the wild-type group.
Conclusion This construction of the first humanized mice carrying a deep intronic variant of PAH provides a new animal model for the pathogenesis and treatment of PKU, and may serve as a reference for future research on the pathogenicity of deep intronic variation.

Related Results

The study and manipulation of the structures of mammalian phenylalanine hydroxylase (PAH)
The study and manipulation of the structures of mammalian phenylalanine hydroxylase (PAH)
Phenylalanine hydroxylase (PAH) is a liver enzyme critical for phenylalanine (Phe) homeostasis. Defective PAH results in aberrantly high Phe levels, the hallmark of phenylketonuria...
Abstract 18124: Skeletal Muscle Proteomic Signature in Pulmonary Arterial Hypertension
Abstract 18124: Skeletal Muscle Proteomic Signature in Pulmonary Arterial Hypertension
Introduction: Most pulmonary arterial hypertension (PAH) patients exhibit severe dyspnea and fatigue resulting in restricted exercise capabilities and poor quality of l...
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
GW24-e2259 Evaluation of atherosclerosis in low density lipoprotein receptor defect mice by ultrasound biomicroscopy
Objectives Low density lipoprotein receptor defect mice model by transgenetic technology was used to detect atherosclerosis by Ultrasound Biology (UBM). And evalu...
Abstract 18643: Role for RUNX2 in Pulmonary Arterial Hypertension
Abstract 18643: Role for RUNX2 in Pulmonary Arterial Hypertension
Introduction: Pulmonary arterial hypertension (PAH) is a vascular remodeling disease characterized by enhanced pulmonary artery smooth muscle cells (PASMC) proliferatio...
Abstract 12577: Pulmonary Endothelial Sulfatase-1 is Regulated by NEDD9 and Increased in Pulmonary Arterial Hypertension
Abstract 12577: Pulmonary Endothelial Sulfatase-1 is Regulated by NEDD9 and Increased in Pulmonary Arterial Hypertension
Introduction: Oxidation of the scaffolding protein NEDD9 by aldosterone (ALDO) increases NEDD9 bioactivity in human pulmonary artery endothelial cells (HPAECs), leading...
Characterization of novel genetic variants causing mitochondrial disease
Characterization of novel genetic variants causing mitochondrial disease
<p dir="ltr">Background. The motivation for this thesis is the desire to improve diagnostics, to increase knowledge about mitochondrial diseases and thus be able to help more...

Back to Top